Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (846) Plenaxis (abarelix for injectable suspension), Praecis Pharmaceuticals,
...Newly Approved Drug Therapies (846) Plenaxis (abarelix for injectable suspension), Praecis Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Plenaxis (abarelix for injectable suspension) Company: Praecis Pharmaceuticals Approval Status: Approved December 2003 Treatment Area: Prostate Cancer ...
View Page

2.  CenterWatch: Oncology Approved Drug Therapies
...For the second-line treatment of non-small-cell lung cancer, Approved May 2003 Plenaxis (abarelix for injectable suspension) ; Praecis Pharmaceuticals; For treatment of advanced prostate cancer, Approved December 2003 Premarin ...
View Page

3.  CenterWatch: List of Newly Approved Drug Thearapies
...For the second-line treatment of non-small-cell lung cancer, Approved May 2003 Plenaxis (abarelix for injectable suspension) ; Praecis Pharmaceuticals; For treatment of advanced prostate cancer, Approved December 2003 Premarin ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (36), Prostate Cancer
...March 17, 2003 Praecis Pharmaceuticals reported positive results from a phase III trial investigating Plenaxis (abarelix injection), a testosterone production inhibitor for the treatment of prostate cancer. Results demonstrated that the ...
View Page